Financial Performance - Revenue for 2023 decreased to RMB 11,168,422 thousand, down from RMB 12,144,980 thousand in 2022[10] - Gross profit for 2023 was RMB 4,334,446 thousand, with a gross margin of 38.8%, compared to 43.3% in 2022[10] - Net profit for 2023 was RMB 1,645,090 thousand, with a net profit margin of 14.7%, down from 20.7% in 2022[10] - Total assets increased to RMB 25,508,284 thousand in 2023, up from RMB 24,359,317 thousand in 2022[10] - Cash and cash equivalents decreased significantly to RMB 5,332,076 thousand in 2023 from RMB 9,762,933 thousand in 2022[10] - Total sales revenue for the period was approximately RMB 11,168,422 thousand, a decrease of 8.0% year-over-year[40] - Revenue from the Chinese mainland market was approximately RMB 163,008 thousand, a significant decrease of 92.7% year-over-year, accounting for 1.5% of total revenue[40] - Revenue from overseas markets was approximately RMB 11,005,414 thousand, an increase of 11.2% year-over-year, accounting for 98.5% of total revenue[40] - Revenue from enterprise customers decreased by 12.7% year-over-year, accounting for 83.5% of total revenue[40] - Revenue from the company's own brand business increased by 26.0% year-over-year, accounting for 16.5% of total revenue[40] - Revenue from the US market for enterprise customers was approximately RMB 4,083,779 thousand, an increase of 8.2% year-over-year, accounting for 36.6% of total revenue[41] - Revenue from Europe and other markets for enterprise customers was approximately RMB 5,074,276 thousand, an increase of 8.9% year-over-year, accounting for 45.4% of total revenue[43] - Revenue from disposable e-vapor products in Europe and other markets was approximately RMB 3,370,149 thousand, a significant increase of 74.5% year-over-year, accounting for 30.2% of total revenue[43] - Revenue from the company's own brand business was approximately RMB 1,847,359 thousand, an increase of 26.0% year-over-year[44] - The company's total R&D expenditure in 2023 was approximately RMB 1,482,846 thousand, an increase of 8.1% compared to the previous year, accounting for 13.3% of revenue[50][51] - The company's R&D expenditure in the electronic nicotine delivery systems sector (including e-cigarettes and heated non-combustible products) was RMB 1,033,899 thousand, accounting for 69.7% of total R&D spending[50] - The company's R&D expenditure in the atomized medical and beauty products sector increased by 67.4% to RMB 277,627 thousand, accounting for 18.7% of total R&D spending[50] - The company's total revenue for the review period was approximately RMB 11,168,422 thousand, a decrease of 8.0% year-on-year[61] - The company's gross profit for the review period was approximately RMB 4,334,446 thousand, a decrease of 17.6% year-on-year, with a gross margin of 38.8% compared to 43.3% in 2022[61] - Revenue from enterprise customers decreased by 12.7% to approximately RMB 9,321,063 thousand, with a significant drop of 92.7% in revenue from the Chinese mainland market[63] - Revenue from the US market increased by 8.2% to approximately RMB 4,083,779 thousand, accounting for 36.6% of total revenue[63] - Revenue from Europe and other regions increased by 8.9% to approximately RMB 5,074,276 thousand, accounting for 45.4% of total revenue[63] - The company's own brand business sales increased by 26.0% to approximately RMB 1,847,359 thousand, accounting for 16.5% of total revenue[62] - Revenue from the company's own-brand business reached approximately RMB 1,847,359 thousand, a year-on-year increase of 26.0%, with revenue from the US at RMB 372,192 thousand (up 8.8%) and from Europe and other regions at RMB 1,475,167 thousand (up 31.3%)[64] - Total revenue for 2023 was RMB 11,168,422 thousand, a decrease of 8.0% compared to 2022, with revenue from Europe and other regions accounting for 45.4% (RMB 5,065,271 thousand), the US at 10.8% (RMB 1,210,769 thousand), and Hong Kong at 36.0% (RMB 4,016,522 thousand)[65] - Revenue from the Chinese mainland market was approximately RMB 875,860 thousand, a significant decrease of 92.7% compared to 2022, accounting for only 1.5% of total revenue after adjustments[66] - Gross profit for 2023 was RMB 4,334,446 thousand, a decrease of 17.6% year-on-year, with the gross margin dropping from 43.3% to 38.8% due to lower-margin products and reduced revenue from the Chinese mainland market[68] - Distribution and sales expenses increased by 35.7% to RMB 526,238 thousand, accounting for 4.7% of total revenue, driven by the expansion of localized marketing teams and increased promotional activities in overseas markets[69] - Employee compensation and benefits within distribution and sales expenses grew by 44.4% to RMB 269,416 thousand, reflecting the company's efforts to strengthen overseas market presence[69] - Market development expenses rose by 42.4% to RMB 129,155 thousand, primarily due to increased marketing activities for new product launches in overseas markets[69] - Travel expenses increased by 22.4% to RMB 34,525 thousand, as the company intensified its overseas market expansion and promotional efforts[70] - Raw material costs accounted for 49.4% of total revenue, up from 41.5% in 2022, driven by the increased proportion of lower-margin disposable e-vapor products[68] - Labor costs decreased by 30.6% to RMB 608,898 thousand, reflecting improved production efficiency and automation, reducing the need for manual labor[68] - Administrative expenses decreased by 24.5% to approximately RMB 867,154 thousand, accounting for 7.8% of revenue, down from 9.5% in the previous year[71] - Employee compensation and benefits decreased by 17.8% to approximately RMB 564,044 thousand, accounting for 5.1% of revenue, down from 5.6% in the previous year[71] - Professional service fees decreased by 38.8% to approximately RMB 100,073 thousand, accounting for 0.9% of revenue, down from 1.3% in the previous year[71] - R&D expenses increased by 8.1% to approximately RMB 1,482,846 thousand, accounting for 13.3% of revenue, up from 11.3% in the previous year[73] - Development costs increased by 25.8% to approximately RMB 466,953 thousand, accounting for 4.2% of revenue, up from 3.1% in the previous year[74] - Other income increased by 24.6% to approximately RMB 619,147 thousand, with bank deposit interest income increasing by 23.9% to RMB 515,056 thousand[75] - Other losses totaled approximately RMB 103,740 thousand, compared to other gains of RMB 133,266 thousand in the previous year[76] - Tax expenses decreased by 34.4% to approximately RMB 291,449 thousand, primarily due to a decrease in taxable profits and the impact of preferential tax rates[78] - Comprehensive income for the year decreased by 37.2% to approximately RMB 1,566,470 thousand, primarily due to a decline in revenue and gross profit margin[79] - The company's current ratio increased to 548.8% as of December 31, 2023, up from 534.9% in the previous year, primarily due to an increase in short-term bank deposits[80][81] - The company's asset-liability ratio was approximately 19.1% as of December 31, 2023, compared to 19.5% in the previous year[84] - The company recorded foreign exchange gains of approximately RMB 19,509 thousand in 2023, compared to RMB 126,711 thousand in 2022[86] - The company incurred losses of approximately RMB 95,810 thousand from forward foreign exchange contracts in 2023, compared to RMB 50,029 thousand in 2022[86] - Approximately 60% of the company's revenue was settled in USD, while 40% was settled in RMB during the reporting period[87] - A 10% increase in the USD/RMB exchange rate would increase the company's comprehensive income by approximately RMB 599,744 thousand, while a 10% decrease would reduce it by the same amount[88] - The company's total employee costs accounted for approximately 23.0% of revenue in 2023, down from 25.0% in 2022[90] - The company invested approximately RMB 1,155,547 thousand in property, plant, equipment, and intangible assets in 2023, compared to RMB 2,478,206 thousand in 2022[92] - As of December 31, 2023, the company had capital commitments of approximately RMB 494,304 thousand for property, plant, and equipment[93] - The company had no bank or financial institution borrowings as of December 31, 2023, and held a bank credit line of RMB 6,000.0 million, of which RMB 1,102.2 million was utilized[83] - The company had no significant contingent liabilities as of December 31, 2023[96] - The annual transaction caps for battery procurement are set at RMB 4,500,000 thousand, RMB 6,000,000 thousand, and RMB 7,500,000 thousand for the years ending December 31, 2023, 2024, and 2025, respectively[101] - Battery product procurement transactions during the review period amounted to approximately RMB 548,638 thousand, accounting for 9.9% of the company's total procurement[102] - The company's independent non-executive directors confirmed that the ongoing connected transactions are conducted under normal commercial terms and are fair and reasonable, aligning with the overall interests of shareholders[104] - The company's auditors issued an unqualified opinion on the ongoing connected transactions, confirming compliance with the relevant agreements and not exceeding the annual cap for 2023[105] - Available distributable reserves stood at RMB 7,440.8 million as of December 31, 2023[155] - Charitable donations amounted to RMB 6.3 million in 2023, down from RMB 8.6 million in 2022[156] - The company proposed a final dividend of HK$0.05 per ordinary share for 2023[160] - The share-based compensation plan accounted for approximately 0.94% of the weighted average number of shares issued in 2023[165] - The pre-IPO share option plan allows for the issuance of up to 319,032,000 shares, representing approximately 5.20% of total issued shares[168] - The exercise price for each share option under the pre-IPO share option plan is RMB 0.38[171] - The pre-IPO share option plan has a validity period from the adoption date (September 30, 2019) to the listing date (July 10, 2020), after which no further options will be granted[172] - Each grantee must pay HKD 1 as consideration for accepting the share options under the pre-IPO share option plan, which is non-refundable and not part of the exercise price[171] - The term of share options is determined by the board and shall not exceed ten years from the date of the option offer[170] - Any unexercised share options will expire after the option term ends[170] - The company granted a total of 16,000,000 share options to Director Chen Zhiping, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.04 to HKD 2.08 per option[174] - Director Wang Guisheng was granted 6,000,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.34 to HKD 2.42 per option[174] - Director Wang Xin received 1,428,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.34 to HKD 2.42 per option[174] - Director Bu Zhiqiang was granted 544,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.34 to HKD 2.42 per option[174] - Director Bu Weiqiang received 290,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.31 to HKD 2.42 per option[174] - Director Li Xiaoping was granted 1,192,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.34 to HKD 2.42 per option[174] - Director Yuan Xiang received 52,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.31 to HKD 2.42 per option[174] - Director Xiong Fei was granted 81,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.34 to HKD 2.42 per option[174] - Non-director employees were granted a total of 73,219,000 share options, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.31 to HKD 2.42 per option[174] - The company granted an additional 37,000 share options to non-director employees, with an exercise price of HKD 0.38 and a fair value ranging from HKD 2.08 to HKD 2.11 per option[174] - The number of share options available under the post-IPO share option plan at the beginning of 2023 was 160,063,272 shares, and at the end of 2023, it was 86,793,572 shares[175] - The maximum number of shares that can be issued under the post-IPO share option plan and other share option plans combined is 574,351,272 shares, which is 10% of the total issued shares as of the listing date[177] - The total number of shares that can be issued under the post-IPO share option plan is 255,319,272 shares, representing approximately 4.16% of the total issued shares of 6,137,238,720 as of the annual report date[177] - The post-IPO share option plan is valid for ten years from the listing date (July 10, 2020), after which no further options will be granted[183] - In 2023, the company granted a total of 85,475,100 share options under the post-IPO share option plan on April 19, July 20, August 23, and October 20[184] - 319,150 stock options were granted to Director Wang Guisheng on 2023/08/23, with exercise prices of HKD 7.79 and fair values ranging from HKD 2.15 to HKD 3.06[185] - 172,825 stock options were granted to Director Xiong Shaoming on 2023/08/23, with exercise prices of HKD 7.79 and fair values ranging from HKD 2.15 to HKD 3.06[185] - 87,650 stock options were granted to Director Wang Xin on 2023/08/23, with exercise prices of HKD 7.79 and fair values ranging from HKD 2.15 to HKD 3.06[185] - 66,500 stock options were granted to Director Wang Guisheng on 2022/11/09, with an exercise price of HKD 11.11 and a fair value of HKD 2.77[185] - 117,000 stock options were granted to Director Xiong Shaoming on 2022/11/09, with an exercise price of HKD 11.11 and fair values of HKD 2.77 and HKD 3.19[185] - 7,500 stock options were granted to Director Wang Xin on 2022/11/09, with an exercise price of HKD 11.11 and fair values of HKD 2.77 and HKD 3.19[185] - 44,333 stock options were granted to Director Wang Guisheng on 2021/04/01, with an exercise price of HKD 51.05 and fair values ranging from HKD 10.15 to HKD 12.40[185] - 78,000 stock options were granted to Director Xiong Shaoming on 2021/04/01, with an exercise price of HKD 51.05 and fair values ranging from HKD 10.15 to HKD 12.40[185] - 5,000 stock options were granted to Director Wang Xin on 2021/04/01, with an exercise price of HKD 51.05 and fair values ranging from HKD 10.15 to HKD 12.40[185] - 21,667 stock options were granted to Li Xiaoping (Director) on 2021/04/01 with an exercise price of HK$51.05 and a vesting period from 2021/04/01 to 2023/03/31[186] - 32,500 stock options were granted to Li Xiaoping (Director) on 2022/11/09 with an exercise price of HK$11.11 and a vesting period from 2022/11/09 to 2024/03/31[186] - 33,550 stock options were granted to Bu

股 票 研 究 [Table_industryInfo] 耐用消费品 [ Table_Main[思I Tnaf 摩bol]e 尔_Ti国tle]际 （6969） [评Tab级le_：Inv est] 增持 当前价格（港元）： 7.07 业绩稳步修复，底层研发持续夯实 2024.04.12 海 思摩尔国际2024Q1 业绩点评 [ 交Ta易bl数e_M据a rket] 外 王佳(分析师) 毛宇翔(研究助理) 52周内股价区间（港元） 4.73-10.20 当前股本（百万股） 6,138 公 010-83939781 0755-23976668 当前市值（百万港元） 43,394 司 wangjia025750@gtjas.com maoyuxiang029547@gtjas.co （ 证书编号 S0880524010001 mS0 880124030007 [ Table_PicQuote] 中 本报告导读： 52周内股价走势图 国 公司业绩稳步修复，多项业务产品、渠道扩张节奏延续，保持23年以来增势。此外， 思摩尔国际 恒生指数 香 公司加大研发力度，基于市场需求洞察，高效创新研发，敏捷回应消费趋势。 1% ...

公 司 研 究 思摩尔国际（06969.HK）：海外收入 2024年4月2日 推荐/维持 稳健增长，雾化新业务逐步落地 东 思摩尔国际 公司报告 兴 证 事件：公司发布2023年度业绩，全年实现收入111.68亿元，同比-8.0%；净 公司简介： 券 利润16.45亿元，同比-34.5%；全面综合收益总额15.66亿元，同比-37.2%。 公司是提供雾化科技解决方案的全球领导 股 者，包括基于ODM制造加热不燃烧产品的 份 海外整体增长稳健，中国大陆市场拖累收入。 电子雾化设备及电子雾化组件，拥有先进的 有  企业客户销售方面，23年实现收入93.21亿元，同比-12.7%。（1）美国 研发技术、雄厚的制造实力、广泛的产品组 限 合及多元化的客户群。 市场全年40.84亿元，低基数下（22年产品降价）稳健增长（+8.2%）， 资料来源：公司公告、同花顺 公 23H2同比有所下滑（-6.3%）。公司助力大客户在换弹产品中提升市占率， 未来3-6个月重大事项提示： 司 不过当地市场仍有大量不合规一次性产品，对公司客户的合规产品有所 无 证 不利。（2）欧洲及其他海外地区 50.74 亿元（+8.9%），公司于 ...

OJacntuoabrey r1 12,22,0 21051 0 BuildFinogo dM, Baetevreiraalsge | &C oTombpa 公accn 司oy | 研R Ce 究osme paarcnhy Research 轻工制造 | 公司研究 海外市场稳健增长，新业务有序发展 2024年03月28日 思摩尔国际（06969.HK）2023 年业绩点评 公司公布2023年业绩，表现基本符合预期：2023年收入111.68亿元，同比-8.0%，净利润16.45 增持 亿元，同比-34.5%；全面综合收益总额15.66亿元，同比-37.2%。 维持 美国市场：换弹式回落，大麻雾化仍在补齐基本能力。2023年美国市场TOB收入40.84亿元，同 比+8%。1）换弹式：预计2023年收入同比回落，主要系美国FDA对一次性电子烟监管执行不够 严格，换弹式份额仍受到一次性冲击；但公司通过提升自动化水平优化成本，助力大客户市占率进 市场数据：2024年03月28日 一步提升，根据尼尔森数据，英美烟草的VUSE市占率自2022年的41.1%提升至2023年的45.6%。 收盘价（港币） 6.66 展望后续 ...

2024 年 3 月 21 日 公司动态 思摩尔（6969.HK） 证券研究报告 电子烟 最坏时刻已经过去 投资评级： Xx 买入 xx 思摩尔2023年收入111.7亿，同比下降8%，净利润16.5亿，同比下降34.5%。毛利率38.8%， 同比下降4.5pct，净利率14.7%，同比下降5.9pct。随着中美两国政策落地，形势明朗，欧 目标价格： 8.1 港元 洲业务和APV业务引领增长，我们认为公司最坏的时刻已经过去，未来有望保持平稳增长。 结合公司短期的业绩下滑，我们下调24/25/26年净利润分别至19.6/20.5/21.1亿元，对应 现价(2024-3-20)： 6.87港元 EPS分别为0.35/0.37/0.38港元。维持“买入”评级，下调目标价至8.1港元，较当前股价 有17%上涨空间。 报告摘要 总市值(百万港元) 42,165.99 欧洲及其他市场保持增长，一次性产品是主要增长动力。23年来自欧洲及其他市场的收入达 流通市值(百万港元) 42,165.99 到50.7亿，同比增长8.9%。公司在上半年推出了升级feelm max陶瓷雾化芯平台，并实现 总股本(百万股) 6,137.70 ...

电子/消费电子 公 司 思摩尔国际（06969.HK）海外市场收入稳步增长，加大研发业务外延寻求突破 研 究 2024年03月21日 ——公司信息更新报告 投资评级：买入（维持） 吕明（分析师） 周嘉乐（分析师） 骆扬（联系人） lvming@kysec.cn zhoujiale@kysec.cn luoyang@kysec.cn 证 书编号：S0790520030002 证书编号：S0790522030002 证书编号：S0790122120029 日期 2024/3/21 当前股价(港元) 7.070  2023年业绩阶段承压，产品结构调整仍在持续，维持“买入”评级 2023 年公司实现营收 111.68 亿元（同比-8.0%），实现净利润 16.45 亿元（同比 公 一年最高最低(港元) 10.880/4.610 -34.5%）。单季度测算，2023Q4公司收入为31.66亿元（同比-3.5%）。公司2023 司 信 总市值(亿港元) 433.94 年收入业绩下滑，主要是中国大陆市场收入下滑较大所致。考虑到公司产品结构 调整仍在持续，低毛利一次性产品占比或继续提升，我们下调2024/2025盈利预 息 ...

海外一次性增长靓丽，高研发投入保持技术优势 思摩尔国际(6969.HK)/轻工 证券研究报告/公司点评 2024年03月20日 [Table_Industry] [评Ta级ble：_T增itle持] （维持） [公Ta司ble盈_F利in预anc测e]及 估值 市场价格：6.91港元 指标 2021A 2022A 2023E 2024E 2025E 营业收入（百万元） 13,755 12,145 11,168 12,378 13,597 分析师：张潇 增长率yoy% 37.4% -11.7% -8.0% 10.8% 9.8% 执业证书编号：S0740523030001 净利润（百万元） 5,287 2,510 1,645 1,744 1,831 Email：zhangxiao06@zts.com.cn 增长率yoy% 120.3% -52.5% -34.5% 6.0% 5.0% 每股收益（元） 0.86 0.41 0.27 0.28 0.30 分析师：邹文婕 每股现金流量 0.59 0.08 0.52 0.28 0.27 执业证书编号：S0740523070001 净资产收益率 33.4% 12.7% 7.9 ...

港股公司报告 | 公司点评 思摩尔国际（06969） 证券研究报告 2024年03月20日 投资评级 中国大陆市场收入或筑底，海外市场持续开拓！ 行业 非必需性消费/家庭电 器及用品 6个月评级 买入（维持评级） 事件：公司发布2023 年度业绩，2023 年公司实现营收111.7 亿元，同比 当前价格 6.87港元 降低8.0%；实现净利润16.45亿元，同比减少34.5%。 目标价格 港元 2023年盈利受产品结构及中国大陆市场影响有所下降，海外收入增长较快 基本数据 ➢ 分版块来看，2023年公司面向企业客户销售（ODM）实现收入93.21 港股总股本(百万股) 6,137.70 亿元（占比83.5%），同比减少12.7%，主要因国内《电子烟管理办法》 港股总市值(百万港元) 42,165.99 及电子烟国家标准推行后短期对需求造成一定影响，2023年公司于中 国大陆市场的销售收入约为1.63亿元，同比降低92.7%；面向零售客 每股净资产(港元) 3.85 户销售（APV）实现收入18.47亿元（占比16.5%），同比增长26.0%， 资产负债率(%) 16.07 主要因公司在 2023 年陆续推出众 ...

%% %% 丨证券研究报告丨 港股研究丨公司点评丨思摩尔国际（6969.HK） [Table_Title] 思摩尔国际 2023A 点评：自主品牌延续亮眼增 长，多元发展和降本增效并进 | --- | --- | |------------------------------------------------------------------------------------------------------------------------|-------| | | | | 报告要点 | | | [Table_Summary] 公司发布 2023 年度业绩报告， 2023 年实现收入 / 净利润 / 全面收益总额 111.68/16.45/15.66 亿 | | 分析师及联系人 [Table_Author] 蔡方羿 仲敏丽 赵智勇 章颖佳 SAC：S0490516060001 SAC：S0490522050001 SAC：S0490517110001 SFC：BRP550 请阅读最后评级说明和重要声明 思摩尔国际（6969.HK） cjzqdt11111 2024-03-20 港股研究丨公司点评 ...

[Table_Title] 一次性&APV 表现突出，多元布局发展可期 证券研究报告 | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...